These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15850832)

  • 1. Role of protein kinase C-delta (PKC-delta) in the generation of the effects of IFN-alpha in chronic myelogenous leukemia cells.
    Kaur S; Parmar S; Smith J; Katsoulidis E; Li Y; Sassano A; Majchrzak B; Uddin S; Tallman MS; Fish EN; Platanias LC
    Exp Hematol; 2005 May; 33(5):550-7. PubMed ID: 15850832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus polymerase impairs interferon-α-induced STA T activation through inhibition of importin-α5 and protein kinase C-δ.
    Chen J; Wu M; Zhang X; Zhang W; Zhang Z; Chen L; He J; Zheng Y; Chen C; Wang F; Hu Y; Zhou X; Wang C; Xu Y; Lu M; Yuan Z
    Hepatology; 2013 Feb; 57(2):470-82. PubMed ID: 22996189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase C-delta (PKC-delta ) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727.
    Uddin S; Sassano A; Deb DK; Verma A; Majchrzak B; Rahman A; Malik AB; Fish EN; Platanias LC
    J Biol Chem; 2002 Apr; 277(17):14408-16. PubMed ID: 11839738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells.
    Huang M; Dorsey JF; Epling-Burnette PK; Nimmanapalli R; Landowski TH; Mora LB; Niu G; Sinibaldi D; Bai F; Kraker A; Yu H; Moscinski L; Wei S; Djeu J; Dalton WS; Bhalla K; Loughran TP; Wu J; Jove R
    Oncogene; 2002 Dec; 21(57):8804-16. PubMed ID: 12483533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPK and Stat1 in IFN-gamma, but not IFN-alpha, signaling.
    Takaoka A; Tanaka N; Mitani Y; Miyazaki T; Fujii H; Sato M; Kovarik P; Decker T; Schlessinger J; Taniguchi T
    EMBO J; 1999 May; 18(9):2480-8. PubMed ID: 10228162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small GTPase RAB45-mediated p38 activation in apoptosis of chronic myeloid leukemia progenitor cells.
    Nakamura S; Takemura T; Tan L; Nagata Y; Yokota D; Hirano I; Shigeno K; Shibata K; Fujie M; Fujisawa S; Ohnishi K
    Carcinogenesis; 2011 Dec; 32(12):1758-72. PubMed ID: 21890458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential activation of protein kinase C delta and JNK is required for interferon-alpha-induced expression of IFIT4.
    Huang X; Yang N; Ou X; Li D; Wang Z; Xie Q; Chen Y; Lin H; Yin G; Wen F
    Cell Signal; 2008 Jan; 20(1):112-9. PubMed ID: 17933493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
    Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
    Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of IFN-alpha and IFN-alpha combined with GM-CSF on expression of the genes related to cell apoptosis of MNCs from bone marrow in CML patients].
    Tang LJ; Chen HC; Peng XH
    Hunan Yi Ke Da Xue Xue Bao; 2000 Dec; 25(6):570-2. PubMed ID: 12516408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Different sensitivity of two chronic myeloid leukemia cell lines to interferon-alpha].
    Li XM; Chen HC; Liu XF; Wu YH; Cao YF
    Ai Zheng; 2003 Oct; 22(10):1047-52. PubMed ID: 14558948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice.
    Golas JM; Arndt K; Etienne C; Lucas J; Nardin D; Gibbons J; Frost P; Ye F; Boschelli DH; Boschelli F
    Cancer Res; 2003 Jan; 63(2):375-81. PubMed ID: 12543790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
    Einat M; Lishner M; Amiel A; Nagler A; Yarkorli S; Rudi A; Kashman Y; Markel D; Fabian I
    Exp Hematol; 1995 Dec; 23(14):1439-44. PubMed ID: 8542929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients.
    Chai SK; Nichols GL; Rothman P
    J Immunol; 1997 Nov; 159(10):4720-8. PubMed ID: 9366395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term culture.
    Schultheis B; Heissig B; Pasternak G; Hörner S; Hehlmann R
    Folia Biol (Praha); 2000; 46(6):251-5. PubMed ID: 11140858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-dependent activation of the serine kinase PI 3'-kinase requires engagement of the IRS pathway but not the Stat pathway.
    Uddin S; Majchrzak B; Wang PC; Modi S; Khan MK; Fish EN; Platanias LC
    Biochem Biophys Res Commun; 2000 Apr; 270(1):158-62. PubMed ID: 10733921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG-DNA-induced IFN-alpha production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors.
    Takauji R; Iho S; Takatsuka H; Yamamoto S; Takahashi T; Kitagawa H; Iwasaki H; Iida R; Yokochi T; Matsuki T
    J Leukoc Biol; 2002 Nov; 72(5):1011-9. PubMed ID: 12429724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the p38 mitogen-activated protein kinase pathway in the generation of arsenic trioxide-dependent cellular responses.
    Giafis N; Katsoulidis E; Sassano A; Tallman MS; Higgins LS; Nebreda AR; Davis RJ; Platanias LC
    Cancer Res; 2006 Jul; 66(13):6763-71. PubMed ID: 16818652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro inducing differentiation of bone marrow mononuclear cells of chronic myeloid leukemia].
    Wu CY; Zhang LS; Zhang YF; Chai Y; Yi LC; Song FX
    Ai Zheng; 2005 Apr; 24(4):425-31. PubMed ID: 15820064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The p38 MAPK pathway mediates the growth inhibitory effects of interferon-alpha in BCR-ABL-expressing cells.
    Mayer IA; Verma A; Grumbach IM; Uddin S; Lekmine F; Ravandi F; Majchrzak B; Fujita S; Fish EN; Platanias LC
    J Biol Chem; 2001 Jul; 276(30):28570-7. PubMed ID: 11353767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic growth inhibitory effects of interferon-alpha and lovastatin on bcr-abl positive leukemic cells.
    Müller-Tidow C; Kiehl M; Sindermann JR; Probst M; Banger N; Zühlsdorf M; Chou TC; Berdel WE; Serve H; Koch OM
    Int J Oncol; 2003 Jul; 23(1):151-8. PubMed ID: 12792788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.